Indian drugmakers Biocon, Eris Lifesciences, and Wockhardt are ramping up insulin production to capture a growing global opportunity, as market leader Novo Nordisk scales back its presence in ...

Tresiba (insulin degludec) has potential interactions with alcohol, other medications, and some supplements. These interactions could affect how well the drug works or cause harmful effects.